Progestational	progestational	O	O
agents	agents	O	O
and	and	O	O
blood	blood	O	B_disease
coagulation	coagulation	O	I_disease
.	.	O	O

VII	vii	O	O
.	.	O	O

Thromboembolic	thromboembolic	O	S_disease
and	and	O	O
other	other	O	O
complications	complications	O	O
of	of	O	O
oral	oral	B_chemical	O
contraceptive	contraceptive	I_chemical	O
therapy	therapy	O	O
in	in	O	O
relationship	relationship	O	O
to	to	O	O
pretreatment	pretreatment	O	O
levels	levels	O	O
of	of	O	O
blood	blood	B_chemical	B_disease
coagulation	coagulation	B_chemical	I_disease
factors	factors	I_chemical	O
:	:	O	O
summary	summary	O	O
report	report	O	O
of	of	O	O
a	a	O	O
ten-year	ten-year	O	O
study	study	O	O
.	.	O	O

During	during	O	O
a	a	O	O
ten-year	ten-year	O	O
period	period	O	O
,	,	O	O
348	348	O	O
women	women	O	O
were	were	O	O
studied	studied	O	O
for	for	O	O
a	a	O	O
total	total	O	O
of	of	O	O
5,877	5,877	O	O
patient	patient	O	O
months	months	O	O
in	in	O	O
four	four	O	O
separate	separate	O	O
studies	studies	O	O
relating	relating	O	O
oral	oral	B_chemical	O
contraceptives	contraceptives	I_chemical	O
to	to	O	O
changes	changes	O	O
in	in	O	O
hematologic	hematologic	O	O
parameters	parameters	O	O
.	.	O	O

Significant	significant	O	O
increases	increases	O	O
in	in	O	O
certain	certain	O	O
factors	factors	O	O
of	of	O	O
the	the	O	O
blood	blood	O	B_disease
coagulation	coagulation	O	I_disease
and	and	O	O
fibrinolysin	fibrinolysin	O	O
systems	systems	O	O
(	(	O	O
factors	factors	O	O
I	i	O	O
,	,	O	O
II	ii	O	O
,	,	O	O
VII	vii	O	O
,	,	O	O
VIII	viii	O	O
,	,	O	O
IX	ix	O	O
,	,	O	O
and	and	O	O
X	x	O	O
and	and	O	O
plasminogen	plasminogen	O	O
)	)	O	O
were	were	O	O
observed	observed	O	O
in	in	O	O
the	the	O	O
treated	treated	O	O
groups	groups	O	O
.	.	O	O

Severe	severe	O	O
complications	complications	O	O
developed	developed	O	O
in	in	O	O
four	four	O	O
patients	patients	O	O
.	.	O	O

All	all	O	O
four	four	O	O
had	had	O	O
an	an	O	O
abnormal	abnormal	O	O
blood	blood	O	B_disease
coagulation	coagulation	O	I_disease
profile	profile	O	O
,	,	O	O
suggesting	suggesting	O	O
"	"	O	O
hypercoagulability	hypercoagulability	O	O
"	"	O	O
before	before	O	O
initiation	initiation	O	O
of	of	O	O
therapy	therapy	O	O
.	.	O	O

Some	some	O	O
of	of	O	O
these	these	O	O
findings	findings	O	O
represented	represented	O	O
the	the	O	O
most	most	O	O
extreme	extreme	O	O
abnormalities	abnormalities	O	O
seen	seen	O	O
in	in	O	O
the	the	O	O
entire	entire	O	O
group	group	O	O
of	of	O	O
patients	patients	O	O
;	;	O	O
some	some	O	O
increased	increased	O	O
further	further	O	O
during	during	O	O
therapy	therapy	O	O
.	.	O	O

One	one	O	O
of	of	O	O
these	these	O	O
patients	patients	O	O
developed	developed	O	O
a	a	O	O
myocardial	myocardial	O	B_disease
infarction	infarction	O	S_disease
before	before	O	O
receiving	receiving	O	O
any	any	O	O
medication	medication	O	O
,	,	O	O
shortly	shortly	O	O
after	after	O	O
the	the	O	O
base-line	base-line	O	O
values	values	O	O
were	were	O	O
obtained	obtained	O	O
.	.	O	O

One	one	O	O
patient	patient	O	O
developed	developed	O	O
retinopathy	retinopathy	O	O
19	19	O	O
months	months	O	O
after	after	O	O
she	she	O	O
began	began	O	O
therapy	therapy	O	O
,	,	O	O
and	and	O	O
another	another	O	O
developed	developed	O	O
thrombophlebitis	thrombophlebitis	O	O
after	after	O	O
27	27	O	O
months	months	O	O
of	of	O	O
therapy	therapy	O	O
.	.	O	O

The	the	O	O
fourth	fourth	O	O
patient	patient	O	O
developed	developed	O	O
thrombophlebitis	thrombophlebitis	O	O
14	14	O	O
days	days	O	O
after	after	O	O
initiation	initiation	O	O
of	of	O	O
contraceptive	contraceptive	O	O
therapy	therapy	O	O
.	.	O	O

All	all	O	O
four	four	O	O
patients	patients	O	O
were	were	O	O
of	of	O	O
the	the	O	O
A	a	O	O
or	or	O	O
AB	ab	O	O
blood	blood	O	O
group	group	O	O
.	.	O	O

Previous	previous	O	O
studies	studies	O	O
suggested	suggested	O	O
the	the	O	O
possiblility	possiblility	O	O
of	of	O	O
increased	increased	O	O
propensity	propensity	O	O
for	for	O	O
thromboembolic	thromboembolic	O	S_disease
episodes	episodes	O	O
in	in	O	O
patients	patients	O	O
possessing	possessing	O	O
the	the	O	O
A	a	O	O
antigen	antigen	O	O
.	.	O	O

It	it	O	O
appears	appears	O	O
from	from	O	O
these	these	O	O
data	data	O	O
that	that	O	O
hematologic	hematologic	O	O
work-ups	work-ups	O	O
may	may	O	O
be	be	O	O
useful	useful	O	O
in	in	O	O
women	women	O	O
who	who	O	O
are	are	O	O
about	about	O	O
to	to	O	O
start	start	O	O
long-term	long-term	O	O
oral	oral	B_chemical	O
contraceptive	contraceptive	I_chemical	O
therapy	therapy	O	O
.	.	O	O

